This report analyzes the worldwide markets for Orphan Drugs in US$ Million by the following Product Segments: Biologics, and Non-Biologics.
The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 140 companies including many key and niche players such as -
Actelion Pharmaceuticals Ltd.
Alexion Pharmaceuticals, Inc.